Third‐Generation Beta‐Adrenoceptor Antagonists in the Treatment of Hypertension and Heart Failure

Publisher： John Wiley & Sons Inc

E-ISSN： 1742-7843|117|1|5-14

ISSN： 1742-7835

Source： BASIC AND CLINICAL PHARMACOLOGY & TOXICOLOGY (ELECTRONIC), Vol.117, Iss.1, 2015-07, pp. : 5-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rivizor – A New Third-Generation Aromatase Inhibitor for the Treatment of Advanced Breast Cancer after Tamoxifen Failure

By  

Oncology, Vol. 56, Iss. 2, 1999-02 ,pp. : 114-121

Karger

Access to resources Recommend Favorite

PREVENTION AND REVERSAL OF ISOLATION‐INDUCED SYSTOLIC ARTERIAL HYPERTENSION IN RATS BY TREATMENT WITH β‐ADRENOCEPTOR ANTAGONISTS

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 65, Iss. 2, 1979-02 ,pp. : 205-213

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment outcomes in patients with third-generation cephalosporin-resistant Enterobacter bacteremia

By O'Neal Catherine S.   O'Neal Hollis R.   Daniels Titus L.   Talbot Thomas R.  

Scandinavian Journal of Infectious Diseases, Vol. 44, Iss. 10, 2012-10 ,pp. : 726-732

Informa Healthcare

Access to resources Recommend Favorite

Problems in assessing beta‐adrenoceptor antagonism in man [editorial].

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 2, Iss. 1, 1975-02 ,pp. : 3-4

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Combination of Valsartan and Sacubitril in the Treatment of Hypertension and Heart Failure – an Update

By  

BASIC AND CLINICAL PHARMACOLOGY & TOXICOLOGY (ELECTRONIC), Vol. 122, Iss. 1, 2018-01 ,pp. : 9-18

John Wiley & Sons Inc

Access to resources Recommend Favorite